An Internet-delivered Cognitive Behavioral Intervention for Sleep Disturbance in Multiple Sclerosis
针对多发性硬化症睡眠障碍的互联网交付认知行为干预
基本信息
- 批准号:9175768
- 负责人:
- 金额:$ 12.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-13 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdverse effectsAffectAftercareAwardBehavioralBehavioral SymptomsChronicChronic InsomniaClinicalClinical ResearchCognitive TherapyDataDoctor of PhilosophyEmotionalEnsureFamily health statusFatigueFunctional disorderFutureGeneral PopulationGoalsGoldHealthHealth PsychologyHealthcareImpaired cognitionIndividualInternetInterventionIntervention StudiesKnowledgeManuscriptsMeasurementMedicalMedicineMental DepressionMentored Patient-Oriented Research Career Development AwardMentorsMissionMultiple SclerosisNeurobehavioral ManifestationsNeuropsychologyNeurorehabilitationNocturiaOutcomeOutcome AssessmentPainParticipantPathway interactionsPharmaceutical PreparationsPopulationPrevalencePublicationsQuality of lifeRandomizedRandomized Controlled TrialsRehabilitation ResearchRehabilitation therapyReportingResearchResearch Project GrantsResearch SupportResearch TrainingSelf-Help DevicesSleepSleep disturbancesSleeplessnessSpasmSymptomsTechnologyTelephoneTemperatureTestingTrainingTranslatingWorkactigraphyarmbasecareerclinical practiceexperiencefallsfollow-upimprovedindividualized medicineinnovationmultiple sclerosis patientneuropsychologicalnovelpatient orientedprogramssatisfactionskillsstandard caretelehealthtreatment as usualtrial comparing
项目摘要
PROJECT SUMMARY
The goal of this K23 Mentored Patient-Oriented Research Career Development Award is for the PI (Abbey J.
Hughes, PhD) to develop a program of research aimed at providing innovative, effective, and accessible
interventions for treating sleep disturbance in individuals with multiple sclerosis (MS). Sleep disturbance is a
significant health problem affecting an astounding 54 to 67% of people with MS. Sleep disturbance is one of
the primary contributors to fatigue, neuropsychological dysfunction, pain, depression, and diminished quality of
life in MS. Although research supports cognitive behavioral therapy for insomnia (CBT-I) as the gold-standard
treatment for sleep disturbance, CBT-I has yet to be adapted and tested in MS. Thus, the objective of this five-
year research project is to develop and evaluate the preliminary effects of an innovative, internet-delivered
cognitive behavioral intervention for sleep disturbance in MS (iSliMS). The specific aims of the proposed
project are to: 1) determine the preliminary effects of iSliMS on sleep efficiency, quantity, and quality; 2)
determine iSliMS treatment satisfaction, adherence, and integrity; and 3) determine the preliminary effects of
iSliMS on fatigue, depression, and neuropsychological dysfunction. This project will feature a randomized
controlled trial (RCT) comparing iSliMS versus treatment as usual (n = 90). To ensure the successful
completion of this project, the PI has developed a training plan of mentored research, didactic training, and
professional activities that will allow her to acquire: 1) expertise in RCTs utilizing patient-oriented outcomes; 2)
expertise in the scientific measurement and cognitive behavioral treatment of sleep disturbance in MS and
other neurorehabilitation populations; 3) foundational knowledge and skills in conducting web and mobile-
based telehealth intervention research; and 4) proficiency in scholarly presentation, manuscript publication,
and grantsmanship. The PI will work collaboratively with a team of leading experts in MS rehabilitation
research, behavioral sleep medicine, intervention technology, and grantsmanship. Led by Drs. Dawn Ehde
(Primary) and Aaron Turner (Co-primary), this team will provide mentored training to support the PI throughout
this award period. Given the overwhelming burden of sleep disturbance in MS, and the limited data on CBT-I in
this population, the proposed research has the potential to advance neurorehabilitation research and promote
more effective clinical practice in MS and other neurorehabilitation populations. Importantly, the training and
research experiences afforded through this K23 proposal will provide an ideal pathway for the PI to: 1) extend
her foundational training in clinical health psychology, neuropsychology, and MS rehabilitation research; 2)
accomplish the proposed study of iSliMS to inform a larger definitive trial; and 3) launch an independent clinical
research career focused on developing, critically evaluating, and disseminating innovative and accessible
clinical interventions to treat cognitive and behavioral symptoms and ultimately improve quality of life for
individuals with MS.
项目摘要
这个K23指导的以患者为导向的研究职业发展奖的目标是为PI(修道院J。
休斯,博士)制定一项研究计划,旨在提供创新,有效和可访问的
治疗多发性硬化症(MS)患者睡眠障碍的干预措施。睡眠障碍是一种
严重的健康问题影响着54%到67%的MS患者。睡眠障碍是其中之一,
疲劳、神经心理功能障碍、疼痛、抑郁和
虽然研究支持失眠的认知行为疗法(CBT-I)作为金标准,
治疗睡眠障碍,CBT-I尚未适应和测试在MS。因此,这五个目标-
一年的研究项目是开发和评估创新的互联网交付的初步效果
认知行为干预治疗MS睡眠障碍(iSlIMS)。建议的具体目标
项目是:1)确定iSlIMS对睡眠效率,数量和质量的初步影响; 2)
确定iSlIMS治疗满意度、依从性和完整性;以及3)确定
iSlIMS对疲劳,抑郁和神经心理功能障碍的影响。该项目将采用随机
对照试验(RCT),比较iSlIMS与常规治疗(n = 90)。确保成功
完成该项目后,PI制定了一项培训计划,包括指导研究、教学培训和
专业活动,使她能够获得:1)利用以患者为导向的结果的RCT专业知识; 2)
在MS睡眠障碍的科学测量和认知行为治疗方面的专业知识,
其他神经康复人群; 3)进行网络和移动的的基础知识和技能-
基于远程医疗干预研究;和4)精通学术演讲,手稿出版,
还有格兰比亚PI将与MS康复领域的领先专家团队合作
研究、行为睡眠医学、干预技术和药物治疗。由Dawn Ehde博士领导
(主要)和Aaron Turner(共同主要),该团队将提供指导培训,以支持PI
这个奖期。鉴于MS中睡眠障碍的巨大负担,以及MS中CBT-I的有限数据,
这一人群,拟议的研究有可能推进神经康复研究和促进
更有效的临床实践在MS和其他神经康复人群。重要的是,培训和
通过K23提案提供的研究经验将为PI提供理想的途径:1)扩展
她在临床健康心理学,神经心理学和MS康复研究方面的基础训练; 2)
完成拟议的iSlIMS研究,为更大规模的确定性试验提供信息;以及3)启动一项独立的临床研究,
研究生涯侧重于开发,批判性评估和传播创新和可访问的
临床干预,以治疗认知和行为症状,并最终改善生活质量,
个人MS
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Abbey Jean Hughes其他文献
Abbey Jean Hughes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 12.51万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 12.51万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 12.51万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 12.51万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 12.51万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 12.51万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 12.51万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 12.51万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 12.51万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 12.51万 - 项目类别:
Fellowship Programs